Published in Arthritis Rheum on February 15, 2009
English language proficiency, health literacy, and trust in physician are associated with shared decision making in rheumatoid arthritis. J Rheumatol (2014) 1.61
Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence. J Rheumatol (2015) 1.40
Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res (2012) 1.37
Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 1.26
Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Rheumtol (2010) 1.11
Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum (2009) 1.03
Understanding preventable hospital readmissions: masqueraders, markers, and true causal factors. J Hosp Med (2011) 0.90
Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study. Pediatr Rheumatol Online J (2014) 0.89
Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2011) 0.89
Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis. Arthritis Rheumatol (2016) 0.86
Association between depression and vascular disease in systemic lupus erythematosus. J Rheumatol (2011) 0.85
Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development. PLoS One (2015) 0.83
Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience. Rheumatol Int (2011) 0.83
Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol (2015) 0.81
Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate. Rheumatol Int (2014) 0.80
Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) (2015) 0.80
Medication adherence, depressive symptoms, and cardiac event-free survival in patients with heart failure. J Card Fail (2013) 0.80
Demographic and Indication-Specific Characteristics Have Limited Association With Social Network Engagement: Evidence From 24,954 Members of Four Health Care Support Groups. J Med Internet Res (2017) 0.79
Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis. Patient Prefer Adherence (2016) 0.78
Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus Cohort. J Clin Cell Immunol (2014) 0.78
Improving treatment adherence in patients with rheumatologic disease. J Musculoskelet Med (2010) 0.77
Lupus nephritis flare in young patients: relapse or nonadherence to treatment? Int J Nephrol Renovasc Dis (2014) 0.77
Severe systemic lupus erythematosus in emergency department: a retrospective single-center study from China. Clin Rheumatol (2011) 0.76
Prevalence and risk factors of anxiety and depression in patients with systemic lupus erythematosus in Southwest China. Rheumatol Int (2016) 0.75
Barriers and facilitators for mental healthcare in pediatric lupus and mixed connective tissue disease: a qualitative study of youth and parent perspectives. Pediatr Rheumatol Online J (2015) 0.75
Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study. BMC Musculoskelet Disord (2016) 0.75
A Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response Modifiers. Clin Ther (2016) 0.75
The association of slow gait speed with trajectories of worsening depressive symptoms in knee osteoarthritis: An observational study. Arthritis Care Res (Hoboken) (2016) 0.75
The informational needs of patients with ANCA-associated vasculitis-development of an informational needs questionnaire. Rheumatology (Oxford) (2014) 0.75
Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized. Dermatol Ther (Heidelb) (2015) 0.75
The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis. Curr Rheumatol Rep (2017) 0.75
Fatigue and depression predict reduced health-related quality of life in childhood-onset lupus. Lupus (2017) 0.75
A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases. Rheumatol Int (2017) 0.75
A Prospective Study of the Impact of Current Poverty, History of Poverty, and Exiting Poverty on Accumulation of Disease Damage in SLE. Arthritis Rheumatol (2017) 0.75
Depressive symptoms moderate the relationship between medication regimen complexity and objectively measured medication adherence in adults with heart failure. J Behav Med (2017) 0.75
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
Impact of medication adherence on hospitalization risk and healthcare cost. Med Care (2005) 9.62
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med (2006) 7.54
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care (2007) 3.40
Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol (2007) 2.62
Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28
Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther (2003) 2.13
Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum (2007) 2.12
Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus (2003) 2.11
Blood pressure measurement in the United Kingdom Heart Disease Prevention Project. J Epidemiol Community Health (1978) 2.11
Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med (1997) 2.00
Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med (1991) 1.79
Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum (2008) 1.71
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol (1997) 1.66
The effect of medication adherence on health care utilization in bipolar disorder. Manag Care Interface (2006) 1.59
An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford) (2006) 1.42
Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol (1986) 1.29
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J (2006) 1.28
An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol (2007) 1.23
Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum (2002) 1.21
Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Soc Sci Med E (1981) 1.17
Predictors of self-reported antidepressant adherence. Behav Med (2007) 1.16
The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy. Br J Rheumatol (1988) 1.15
Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol (2006) 1.14
Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol (1993) 1.07
Lupus patients in an emergency unit. Causes of consultation, hospitalization and outcome. A cohort study. Lupus (2000) 1.06
Quality of life in systemic lupus erythematosus: a controlled study. J Rheumatol (1999) 1.00
Management and treatment perceptions among young adults with asthma in Melbourne: the Australian experience from the European Community Respiratory Health Survey. Respirology (2000) 0.86
Forgetfulness: a role in noncompliance with antidepressant treatment. Can J Psychiatry (2006) 0.84
Evaluation of a short form of the POMS-Depression scale. J Clin Psychol (1985) 0.81
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet (2004) 13.71
Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet (2008) 12.51
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. N Engl J Med (2007) 12.24
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet (2010) 9.90
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med (2007) 9.80
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med (2008) 9.61
Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet (2008) 7.07
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) (2012) 6.51
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet (2009) 5.75
Implementation of a voluntary hospitalist service at a community teaching hospital: improved clinical efficiency and patient outcomes. Ann Intern Med (2002) 5.60
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum (2005) 5.18
Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2004) 4.77
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A (2007) 4.71
Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet (2008) 4.33
PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet (2005) 3.95
Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med (2009) 3.84
Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum (2003) 3.73
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet (2009) 3.52
Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) (2012) 3.47
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet (2009) 3.36
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum (2005) 2.88
Development of classification and response criteria for rheumatic diseases. Arthritis Rheum (2006) 2.88
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet (2011) 2.54
Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question. Arthritis Care Res (Hoboken) (2013) 2.53
Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet (2002) 2.47
Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2002) 2.43
Mexican American ancestry-informative markers: examination of population structure and marker characteristics in European Americans, Mexican Americans, Amerindians and Asians. Hum Genet (2003) 2.27
Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. JAMA (2011) 2.17
Data for Genetic Analysis Workshop 16 Problem 1, association analysis of rheumatoid arthritis data. BMC Proc (2009) 2.12
Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum (2007) 2.12
Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 2.11
Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am (2005) 2.11
Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy. Arthritis Rheum (2010) 2.08
Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health (2005) 2.04
Clustering of disease features within 512 multicase rheumatoid arthritis families. Arthritis Rheum (2004) 2.00
Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet (2011) 1.92
Pain, functional limitations, and aging. J Am Geriatr Soc (2009) 1.88
Depressive symptoms in middle age and the development of later-life functional limitations: the long-term effect of depressive symptoms. J Am Geriatr Soc (2010) 1.88
Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum (2007) 1.83
Markers informative for ancestry demonstrate consistent megabase-length linkage disequilibrium in the African American population. Hum Genet (2003) 1.80
Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet (2008) 1.80
Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol (2011) 1.77
A quality indicator set for systemic lupus erythematosus. Arthritis Rheum (2009) 1.77
TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry (2013) 1.74
Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum (2008) 1.71
2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag (2013) 1.70
Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus. Mol Med (2008) 1.69
Measuring hospital quality using pediatric readmission and revisit rates. Pediatrics (2013) 1.68
Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet (2007) 1.66
A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet (2011) 1.62
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol (2014) 1.62
High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet (2009) 1.61
Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet (2011) 1.59
Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet (2011) 1.57
Development and validation of a survey-based COPD severity score. Chest (2005) 1.57
Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. PLoS Genet (2013) 1.54
Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest (2009) 1.54
The influence of chronic respiratory conditions on health status and work disability. Am J Public Health (2002) 1.53
A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2. PLoS Genet (2008) 1.53
Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum (2004) 1.50
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet (2011) 1.49
Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun (2013) 1.47
Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women. J Rheumatol (2002) 1.46
Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD. Prim Care Respir J (2012) 1.45
Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med (2002) 1.45
An early view of the international Sjögren's syndrome registry. Arthritis Rheum (2009) 1.43
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet (2010) 1.43
Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. Arthritis Rheum (2011) 1.42
Value of the HLA-DRB1 shared epitope for predicting radiographic damage in rheumatoid arthritis depends on the individual patient risk profile. J Rheumatol (2006) 1.41
Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates. Arthritis Rheum (2004) 1.41
Association between etanercept use and employment outcomes among patients with rheumatoid arthritis. Arthritis Rheum (2003) 1.41
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet (2012) 1.41
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis (2011) 1.41
PTPN22: its role in SLE and autoimmunity. Autoimmunity (2007) 1.38
Data for Genetic Analysis Workshop (GAW) 15 Problem 2, genetic causes of rheumatoid arthritis and associated traits. BMC Proc (2007) 1.36
Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol (2003) 1.35
Recent advances in the genetics of systemic lupus erythematosus. Expert Rev Clin Immunol (2010) 1.35
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum (2009) 1.31
Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum (2009) 1.28
Markers that discriminate between European and African ancestry show limited variation within Africa. Hum Genet (2002) 1.27
Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. Arthritis Rheum (2007) 1.26
Exposure to vapors, gas, dust, or fumes: assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix. Am J Ind Med (2005) 1.26